Suneel Chilukuri, MD: Combination Approach to Hyperpigmentation: Unveiling Enhanced Aesthetic Results With Microneedling and Pigment-Correcting Peel

June 3, 2026

Suneel Chilukuri, MD, discusses original research published in the June 2026 issue of JCAD. This study involved 31 patients who were administered a combination treatment that included a microneedling and pigment-correcting chemical peel. The results showed the chemical peel with microneedling was more effective in reducing erythema and improving skin brightness compared to microneedling alone. By the third treatment session, both methods showed similar improvements.

Read the full article here

Topics covered:

Results of combining a pigment-correcting peel with microneedling
Assessing ingredients of the formulation
Reviewing potential adverse events for this treatment

MORE JOURNAL REVIEWS:

Peter Lio, MD: PDE4 Inhibitor-Responsive Dermatoses: An Emerging Concept in Dermatology

Dr. Lio discusses his article published in the December 2025 issue of JCAD, titled “PDE4 Inhibitor-Responsive Dermatoses: An Emerging Concept in Dermatology.” Read the full

Hawasatu Dumbuya, PhD: Efficacy of a 2-MNG-Containing Serum and Sunscreen Regimen on Improving Facial Dyschromia in Women with Skin of Color

Dr. Dumbuya discusses her article published in JCAD October 2025, titled “Efficacy of a 2-MNG-Containing Serum and Sunscreen Regimen on Improving Facial Dyschromia in Women

Marianna Blyumin-Karasik, MD: What Are Topical Adaptogens? A Systematic Review and Proposed System to Identify and Categorize Skin Adaptogens in Dermatology

Dr. Marianna Blyumin-Karasik reviews a new JCAD article proposing a system to identify and classify topical adaptogens in dermatology. Topics Covered: Definition and scope of

Christopher Bunick, MD, PhD, and James Del Rosso, DO: Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% to Treat Acne Induced by Janus Kinase Inhibitor Treatment: A Case Report

Drs. Bunick and Del Rosso discuss an article published in JCAD September 2025, titled “Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% to Treat Acne Induced by

Diego Ruiz Dasilva, MD: Nemolizumab Demonstrates Marked Efficacy in Challenging Chronic Pruritus: A Real-world Multicenter Case Series

Dr. Dasilva discusses his article published in JCAD September 2025, titled “Nemolizumab Demonstrates Marked Efficacy in Challenging Chronic Pruritus: A Real-world Multicenter Case Series.” Read

Michael Cameron, MD, FAAD, and Christopher Bunick, MD, PhD: The Future of Personalized Atopic Dermatitis Treatments to Predict and Avoid Adverse Events

Drs. Bunick and Cameron discuss a case series recently published in the May 2025 issue of The Journal of Clinical and Aesthetic Dermatology that describes

James Del Rosso, DO, and Christopher Bunick, MD: Tralokinumab as a Therapeutic Alternative for Dupilumab-associated Arthralgia in Atopic Dermatitis—A Multi-center Case Series

Drs. Bunick and Del Rosso discuss a case series published in the May 2025 issue of The Journal of Clinical and Aesthetic Dermatology that describes

Naiem Issa, MD, PhD, and Christopher Bunick, MD, PhD: Mechanisms of Dupilumab-associated Arthralgia in Patients with Atopic Dermatitis

Drs. Issa and Bunick dive into the possible mechanistic explanations behind arthralgia associated with dupilumab, which was detailed in a case series by Drs. Issa

Emmy Graber, MD, MBA: Prospective Pilot Evaluation of the Safety, Tolerability, and Efficacy of Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel plus Clascoterone 1% Cream in Adult Patients with Acne

Dr. Emmy Graber presents pilot study results on a combination acne regimen featuring clindamycin/adapalene/BPO gel plus clascoterone cream in adult patients. Topics Covered: Combination topical

Naiem T. Issa, MD, PhD: Real-World Use of Tapinarof Cream 1% Once Daily in Patients with Seborrheic Dermatitis: A Case Series

Dr. Naiem T. Issa presents a case series on the real-world application of Tapinarof Cream 1% once daily in patients with seborrheic dermatitis, highlighting its

Nada Elbuluk, MD, MSc: Utilization of Internet and Social Media by Outpatient Dermatology Patients: A Prospective, Cross-sectional Study

Dr. Nada Elbuluk presents findings on how outpatient dermatology patients use the internet and social media to acquire dermatology-related information. Topics Covered: Patient behavior in

Tina Bhutani, MD: Improvement in Patient-reported Symptoms and Satisfaction with Tildrakizumab in a Real-world Study in Patients with Moderate-to-severe Plaque Psoriasis

Dr. Tina Bhutani reviews real-world data showing improved patient-reported outcomes and satisfaction with tildrakizumab in moderate-to-severe plaque psoriasis. Read the full article here Topics Covered:

Alice Gottlieb, MD, PhD: Diagnostic Delay of Psoriatic Arthritis of More Than Six Months Contributes to Poor Patient-Reported Outcome Measures in Depression, Social Ability, and Disease Impact

Alice Gottlieb, MD, PhD, discusses a new article published in the October 2024 issue of JCAD that sought to correlate the time lag between psoriatic

James Del Rosso, DO: Clindamycin— A Comprehensive Status Report with Emphasis on Use in Dermatology

James Del Rosso, DO, Clinical Editor-in-Chief of JCAD, discusses a new review article published in the August 2024 issue of JCAD, titled “Clindamycin: A Comprehensive

Journal Review: Andrew Blauvelt

Andrew Blauvelt, MD, MBA, a dermatologist at the Oregon Medical Research Center in Portland, Oregon, discusses the impact Ruxolitinib cream has on itch in patients

Journal Review: Linda Stein Gold

Linda Stein Gold, MD, discusses an article published in the Journal of Drugs in Dermatology titled, "Halobetasol 0.01%/Tazarotene 0.045% Lotion in the Treatment of Moderate-to-Severe

Journal Review: Valerie Callender

Valerie Callender, MD, is the Founder and Medical Director of the Callender Dermatology & Cosmetic Center, and is known for her sensitive and cutting-edge approach

Journal Review: Nanette Silverberg (Full Manuscript)

Nanette Silverberg, MD, a Clinical Professor of Pediatrics and Dermatology at the Icahn School of Medicine at Mount Sinai in New York, New York, provides

Journal Review: Sabrina Fabi

Sabrina Fabi, MD, discusses the article, “Customized Treatment Using Microfocused Ultrasound with Visualization for OptimizedPatient Outcomes: A Review of Skin-tightening Energy Technologies and a Pan-Asian

JCAD Archives